Xcout IntelCreative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Subscribe to see Creative Medical Technology Holdings, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Creative Medical Technology Holdings, Inc. at a glance
Creative Medical Technology Holdings, Inc. is a biotech company headquartered in Phoenix, United States. It is publicly listed (CELZ) with a market capitalisation of $2.8M. Xcout tracks 9 named people at Creative Medical Technology Holdings, Inc., including Donald Dickerson (Senior Vice President, Chief Financial Officer & Director).
Creative Medical Technology Holdings, Inc. leadership
- Donald DickersonSenior Vice President, Chief Financial Officer & Director
- Timothy WarbingtonCo-Founder, Chairman, President & Chief Executive Officer
- Amit Nilkanth PatelDirector
- Courtney BartlettDirector of Clinical Development
- Donald DickersonDirector
- Michael H. FingerDirector
3 more named people on record for Creative Medical Technology Holdings, Inc., with roles, board committees and tenure — see the full roster →
Creative Medical Technology Holdings, Inc. competitors
A few of Creative Medical Technology Holdings, Inc.'s closest competitors — see the full list of competitors and alternatives →
Operating from its Tokyo headquarters, Cytori Cell Research Institute, Inc., established in 2004 (originally FRACTALE Corporation), specializes in the comprehensive research, development, production, and distribution of medical devices related to cell therapy throughout Japan. The company offers various cell therapy kits and continuously advances cellular treatment technologies through ongoing research and development. Its active development pipeline includes ECCI-50, designed for the treatment of male stress urinary incontinence and hepatic cirrhosis, and Cyt-006, formulated to prevent postoperative adhesion after primary rectal cancer surgery. Additionally, Cytori conducts extensive clinical trials and investigations into cell-based therapies for a wide array of conditions and applications, such as the repair of anterior cruciate ligaments and bones, burn scar remediation, chronic wound healing, critical limb ischemia, treatment of anal and Crohn's disease fistulas, and erectile dysfunction. Beyond its primary biotechnological focus, the company also participates in the real estate sector, encompassing investment, ownership, development, leasing, and management of properties and hotels, as well as providing real estate brokerage services.
Cynata Therapeutics is a biotechnology research company headquartered in Cremorne, Australia, focused on therapeutic products and stem cell technology.
CBMG Holdings, formerly known as Cellular Biomedicine Group, is a clinical-stage biopharmaceutical company specializing in the development of immunotherapies for cancers and stem cell therapies. The company focuses on immune cell therapies and T cell-based therapeutics. It has subsequently announced a name change to AbelZeta Pharma, Inc.
Paterna Biosciences develops in vitro spermatogenesis technology to address male infertility and improve in vitro fertilization success rates. The company uses a patient's own adult testicular stem cells to generate healthy sperm and advance reproductive health solutions for couples struggling to conceive.
Conception Holdings, Inc. develops stem cell technology and computational platforms to generate functional human eggs in the lab through in-vitro gametogenesis. The company aims to expand reproductive options for individuals facing biological and medical fertility limits by recreating key steps of human development.
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
Get Creative Medical Technology Holdings, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Creative Medical Technology Holdings, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access